Sanofi
SAN
주식 순위
#224
Sanofi is a global healthcare enterprise dedicated to the research,... Sanofi is a global healthcare enterprise dedicated to the research, development, manufacturing, and commercialization of therapeutic solutions across the United States, Europe, and other international markets. Its business is structured into three primary divisions: Pharmaceuticals, Vaccines, and Consumer Healthcare. The Pharmaceuticals segment delivers specialized treatments, encompassing human monoclonal antibodies and therapies for a range of conditions such as multiple sclerosis, neurological disorders, various inflammatory and immunological diseases, rare disorders, oncology, and rare blood conditions. This division also provides medications for diabetes, cardiovascular health, and a portfolio of established prescription drugs. Through its Vaccines division, Sanofi supplies crucial immunizations, including pediatric vaccines for diseases like poliomyelitis, pertussis, and Hib, alongside adult vaccines addressing influenza, booster needs, meningitis, and those required for travel or endemic regions. The Consumer Healthcare portfolio features over-the-counter remedies for common ailments such as allergies, coughs and colds, and pain relief. It also includes products for liver care, general physical and mental wellness, probiotics, digestive health, and nutritional support. Additionally, this segment offers personal care items like daily body lotions, anti-itch products, moisturizing and soothing lotions, body and foot creams, and powders for eczema. Sanofi maintains an active pipeline with numerous pharmaceutical products and vaccines currently undergoing various stages of development. The company has forged strategic alliances, including a collaboration with GlaxoSmithKline for the development of a recombinant Covid-19 vaccine, a research partnership with Stanford University School of Medicine aimed at advancing immunology and inflammation knowledge, and a collaboration and license option agreement with Prellis Biologics, Inc. Founded in 1973 and headquartered in Paris, France, the company operated as Sanofi-Aventis before rebranding to Sanofi in May 2011.
주가
$83.84
시가총액
$100.45B
변동 (1일)
1.48%
변동 (1년)
-16.74%
국가
FR
거래 Sanofi (SAN)
카테고리
Healthcare
Sanofi (SAN)의 주식 분할 이력
Sanofi 주식 (심볼: SAN)은 총 5회의 주식 분할을 거쳤습니다.
가장 최근의 분할은 May 25, 1999에 발생했습니다.
Jun 10, 1991 이전에 매수한 SAN 주식 1주는 현재 18.5088288주의 SAN 주식에 해당합니다.
가장 최근의 분할은 May 25, 1999에 발생했습니다.
Jun 10, 1991 이전에 매수한 SAN 주식 1주는 현재 18.5088288주의 SAN 주식에 해당합니다.
주식 분할 목록
| 연도 | 주식 분할 | 배수 | 누적 배수 |
|---|---|---|---|
| 1999-05-25 | 4:1 | x4 | x18.5088288 |
| 1995-10-02 | 11:10 | x1.1 | x4.6272072 |
| 1994-09-27 | 4:1 | x4 | x4.206552 |
| 1992-06-05 | 511:500 | x1.022 | x1.051638 |
| 1991-06-10 | 1029:1000 | x1.029 | x1.029 |
유사 기업 또는 경쟁사의 주식 분할
| 회사 | 주식 분할 횟수 | 누적 배수 | 국가 |
|---|---|---|---|
| 4 | x15 |
US
|
|
| 7 | x432 |
US
|
|
| 0 | - |
US
|
|
| 7 | x226 |
US
|
|
| 2 | x10000 |
CH
|
